{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:42:26Z","timestamp":1784166146686,"version":"3.55.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00203-023-03553-5","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T18:05:17Z","timestamp":1683569117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Uropathogenic Escherichia coli endeavors: an insight into the characteristic features, resistance mechanism, and treatment choice"],"prefix":"10.1007","volume":"205","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1176-8472","authenticated-orcid":false,"given":"Vahid","family":"Arafi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6648-0893","authenticated-orcid":false,"given":"Alka","family":"Hasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0649-1352","authenticated-orcid":false,"given":"Javid","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3740-5370","authenticated-orcid":false,"given":"Mojtaba","family":"Varshochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5409-2121","authenticated-orcid":false,"given":"Vahdat","family":"Poortahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9461-821X","authenticated-orcid":false,"given":"Akbar","family":"Hasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3482-2403","authenticated-orcid":false,"given":"Roqaiyeh","family":"Hasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"3553_CR1","doi-asserted-by":"publisher","first-page":"e0201613","DOI":"10.1371\/journal.pone.0201613","volume":"13","author":"M Abd El Ghany","year":"2018","unstructured":"Abd El Ghany M, Sharaf H, Al-Agamy MH, Shibl A, Hill-Cawthorne GA, Hong P-Y (2018) Genomic characterization of NDM-1 and 5, and OXA-181 carbapenemases in uropathogenic Escherichia coli isolates from Riyadh, Saudi Arabia. Plos One 13:e0201613","journal-title":"Plos One"},{"key":"3553_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4103\/0255-0857.96657","volume":"30","author":"J Agarwal","year":"2012","unstructured":"Agarwal J, Srivastava S, Singh M (2012) Pathogenomics of uropathogenic Escherichia coli. Indian J Med Microbiol 30:141\u2013149","journal-title":"Indian J Med Microbiol"},{"key":"3553_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/pathogens9020102","volume":"9","author":"RE Ahumada-Cota","year":"2020","unstructured":"Ahumada-Cota RE, Hernandez-Chi\u00f1as U, Mili\u00e1n-Suazo F, Ch\u00e1vez-Berrocal ME, Navarro-Oca\u00f1a A, Mart\u00ednez-G\u00f3mez D, Pati\u00f1o-L\u00f3pez G, Salazar-Jim\u00e9nez EP, Eslava CA (2020) Effect and analysis of bacterial lysates for the treatment of recurrent urinary tract infections in adults. Pathogens 9:102","journal-title":"Pathogens"},{"key":"3553_CR4","doi-asserted-by":"publisher","first-page":"100911","DOI":"10.1016\/j.genrep.2020.100911","volume":"21","author":"AT Al-Sa'ady","year":"2020","unstructured":"Al-Sa\u2019ady AT, Mohammad GJ, Hussen BM (2020) Genetic relation and virulence factors of carbapenemase-producing Uropathogenic Escherichia coli from urinary tract infections in Iraq. Gene Rep 21:100911","journal-title":"Gene Rep"},{"key":"3553_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.tim.2004.07.005","volume":"12","author":"GG Anderson","year":"2004","unstructured":"Anderson GG, Dodson KW, Hooton TM, Hultgren SJ (2004) Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Trends Microbiol 12:424\u2013430","journal-title":"Trends Microbiol"},{"key":"3553_CR6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0025-7125(05)70542-3","volume":"81","author":"CD Bacheller","year":"1997","unstructured":"Bacheller CD, Bernstein JM (1997) Urinary tract infections. Med Clin North Am 81:719\u2013730","journal-title":"Med Clin North Am"},{"key":"3553_CR7","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1007\/s00284-020-02173-2","volume":"77","author":"R Baldiris-Avila","year":"2020","unstructured":"Baldiris-Avila R, Montes-Robledo A, Buelvas-Montes Y (2020) Phylogenetic classification, biofilm-forming capacity, virulence factors, and antimicrobial resistance in uropathogenic Escherichia coli (UPEC). Curr Microbiol 77:3361\u20133370","journal-title":"Curr Microbiol"},{"key":"3553_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/IDR.S226215","volume":"13","author":"MG Ballesteros-Monrreal","year":"2020","unstructured":"Ballesteros-Monrreal MG, Arenas-Hern\u00e1ndez MM, Enciso-Mart\u00ednez Y, Mart\u00ednez-de la Pe\u00f1a CF, R. del C Rocha-Gracia, P. Lozano-Zara\u00edn, A. Navarro-Oca\u00f1a, Y. Mart\u00ednez-Laguna, and R. de la Rosa-L\u00f3pez. (2020) Virulence and resistance determinants of uropathogenic Escherichia coli strains isolated from pregnant and non-pregnant women from two states in Mexico. Infection and Drug Resistance 13:295","journal-title":"Infection and Drug Resistance"},{"key":"3553_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eursup.2016.04.003","volume":"15","author":"R Bartoletti","year":"2016","unstructured":"Bartoletti R, Cai T, Wagenlehner FM, Naber K, Johansen TEB (2016) Treatment of urinary tract infections and antibiotic stewardship. Eur Urol Suppl 15:81\u201387","journal-title":"Eur Urol Suppl"},{"key":"3553_CR10","doi-asserted-by":"publisher","first-page":"e02400","DOI":"10.1128\/mBio.02400-18","volume":"10","author":"CJ Beebout","year":"2019","unstructured":"Beebout CJ, Eberly AR, Werby SH, Reasoner SA, Brannon JR, De S, Fitzgerald MJ, Huggins MM, Clayton DB, Cegelski L (2019) Respiratory heterogeneity shapes biofilm formation and host colonization in uropathogenic Escherichia coli. Mbio 10:e02400-02418","journal-title":"Mbio"},{"key":"3553_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.tcmj.2016.04.005","volume":"28","author":"N Begum","year":"2016","unstructured":"Begum N, Shamsuzzaman S (2016) Emergence of carbapenemase-producing urinary isolates at a tertiary care hospital in Dhaka, Bangladesh. Tzu Chi Med J 28:94\u201398","journal-title":"Tzu Chi Med J"},{"key":"3553_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/diseases8020017","volume":"8","author":"P Behzadi","year":"2020","unstructured":"Behzadi P, Urb\u00e1n E, Gajd\u00e1cs M (2020) Association between biofilm-production and antibiotic resistance in uropathogenic Escherichia coli (UPEC): an in vitro study. Diseases 8:17","journal-title":"Diseases"},{"key":"3553_CR13","first-page":"571","volume":"59","author":"WG Bessler","year":"2009","unstructured":"Bessler WG, Puce K, U. vor dem Esche, C. Kirschning, and M. Huber. (2009) Immunomodulating effects of OM-89, a bacterial extract from Escherichia coli, in murine and human leukocytes. Arzneimittelforschung 59:571\u2013577","journal-title":"Arzneimittelforschung"},{"key":"3553_CR14","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.2174\/092986711797189655","volume":"18","author":"S Biondi","year":"2011","unstructured":"Biondi S, Long S, Panunzio M, Qin WL (2011) Current trends in \u03b2-lactam based \u03b2-lactamases inhibitors. Curr Med Chem 18:4223\u20134236","journal-title":"Curr Med Chem"},{"key":"3553_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nm1572","volume":"13","author":"BL Bishop","year":"2007","unstructured":"Bishop BL, Duncan MJ, Song J, Li G, Zaas D, Abraham SN (2007) Cyclic AMP\u2013regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med 13:625\u2013630","journal-title":"Nat Med"},{"key":"3553_CR16","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1128\/AAC.00014-10","volume":"54","author":"MG Blango","year":"2010","unstructured":"Blango MG, Mulvey MA (2010) Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 54:1855\u20131863","journal-title":"Antimicrob Agents Chemother"},{"key":"3553_CR17","doi-asserted-by":"publisher","first-page":"e93327","DOI":"10.1371\/journal.pone.0093327","volume":"9","author":"MG Blango","year":"2014","unstructured":"Blango MG, Ott EM, Erman A, Veranic P, Mulvey MA (2014) Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs. PLoS ONE 9:e93327","journal-title":"PLoS ONE"},{"key":"3553_CR18","doi-asserted-by":"publisher","first-page":"e01076","DOI":"10.1128\/AAC.01076-18","volume":"62","author":"K Bush","year":"2018","unstructured":"Bush K (2018) Past and present perspectives on \u03b2-lactamases. Antimicrob Agents Chemother 62:e01076-e1018","journal-title":"Antimicrob Agents Chemother"},{"key":"3553_CR19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.21037\/atm.2016.09.14","volume":"4","author":"Y Cag","year":"2016","unstructured":"Cag Y, Caskurlu H, Fan Y, Cao B, Vahaboglu H (2016) Resistance mechanisms. Ann Transl Med 4:326","journal-title":"Ann Transl Med"},{"key":"3553_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/mdr.2014.0087","volume":"21","author":"Z Chen","year":"2015","unstructured":"Chen Z, Wang Y, Tian L, Zhu X, Li L, Zhang B, Yan S, Sun Z (2015) First report in China of Enterobacteriaceae clinical isolates coharboring bla NDM-1 and bla IMP-4 drug resistance genes. Microb Drug Resist 21:167\u2013170","journal-title":"Microb Drug Resist"},{"key":"3553_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"Y-C Chen","year":"2020","unstructured":"Chen Y-C, Chang C-C, Chiu TH, Lin M-N, Lin C-L (2020) The risk of urinary tract infection in vegetarians and non-vegetarians: a prospective study. Sci Rep 10:1\u20139","journal-title":"Sci Rep"},{"key":"3553_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/1758-2229.12019","volume":"5","author":"O Clermont","year":"2013","unstructured":"Clermont O, Christenson JK, Denamur E, Gordon DM (2013) The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep 5:58\u201365","journal-title":"Environ Microbiol Rep"},{"key":"3553_CR23","first-page":"1","volume":"6","author":"FS Codjoe","year":"2018","unstructured":"Codjoe FS, Donkor ES (2018) Carbapenem resistance: a review. Med Sci 6:1","journal-title":"Med Sci"},{"key":"3553_CR24","unstructured":"Control, C. f. D., and Prevention. 2019. 2019 AR Threats Report."},{"key":"3553_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-12015-0","volume":"7","author":"M De Toro","year":"2017","unstructured":"De Toro M, Fern\u00e1ndez J, Garc\u00eda V, Mora A, Blanco J, De La Cruz F, Rodicio MR (2017) Whole genome sequencing, molecular typing and in vivo virulence of OXA-48-producing Escherichia coli isolates including ST131 H 30-Rx, H 22 and H 41 subclones. Sci Rep 7:1\u201312","journal-title":"Sci Rep"},{"key":"3553_CR26","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.2147\/IDR.S228612","volume":"12","author":"GM De Souza","year":"2019","unstructured":"De Souza GM, Neto ERDS, Da Silva AM, de Souza Iacia MVM, Rodrigues MVP, Pereira VC, Winkelstroter LK (2019) Comparative study Of genetic diversity, virulence genotype, biofilm formation and antimicrobial resistance of Uropathogenic Escherichia coli (UPEC) isolated from nosocomial and community acquired urinary tract infections. Infect Drug Resist 12:3595","journal-title":"Infect Drug Resist"},{"key":"3553_CR27","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.3390\/molecules25153523","volume":"25","author":"D Gonz\u00e1lez de Llano","year":"2020","unstructured":"Gonz\u00e1lez de Llano D, Moreno-Arribas M, Bartolom\u00e9 B (2020) Cranberry polyphenols and prevention against urinary tract infections: relevant considerations. Molecules 25:3523","journal-title":"Molecules"},{"key":"3553_CR28","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.bbapap.2008.11.005","volume":"1794","author":"AH Delcour","year":"2009","unstructured":"Delcour AH (2009) Outer membrane permeability and antibiotic resistance. Biochim et Biophys Acta (BBA) 1794:808\u2013816","journal-title":"Biochim et Biophys Acta (BBA)"},{"key":"3553_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.chom.2011.12.003","volume":"11","author":"BK Dhakal","year":"2012","unstructured":"Dhakal BK, Mulvey MA (2012) The UPEC pore-forming toxin \u03b1-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell Host Microbe 11:58\u201369","journal-title":"Cell Host Microbe"},{"key":"3553_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/jac\/dkw350","volume":"72","author":"MC Di Luca","year":"2016","unstructured":"Di Luca MC, S\u00f8rum V, Starikova I, Kloos J, H\u00fclter N, Naseer U, Johnsen PJ, Samuelsen \u00d8 (2016) Low biological cost of carbapenemase-encoding plasmids following transfer from Klebsiella pneumoniae to Escherichia coli. J Antimicrob Chemother 72:85\u201389","journal-title":"J Antimicrob Chemother"},{"key":"3553_CR31","doi-asserted-by":"publisher","first-page":"e1005083","DOI":"10.1371\/journal.ppat.1005083","volume":"11","author":"N Dikshit","year":"2015","unstructured":"Dikshit N, Bist P, Fenlon SN, Pulloor NK, Chua CEL, Scidmore MA, Carlyon JA, Tang BL, Chen SL, Sukumaran B (2015) Intracellular uropathogenic E. coli exploits host Rab35 for iron acquisition and survival within urinary bladder cells. PLoS Pathog 11:e1005083","journal-title":"PLoS Pathog"},{"key":"3553_CR32","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cmi.2019.04.013","volume":"25","author":"E Durante-Mangoni","year":"2019","unstructured":"Durante-Mangoni E, Andini R, Zampino R (2019) Management of carbapenem-resistant Enterobacteriaceae infections. Clin Microbiol Infect 25:943\u2013950","journal-title":"Clin Microbiol Infect"},{"key":"3553_CR33","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1080\/21645515.2020.1834807","volume":"17","author":"GR Eldridge","year":"2021","unstructured":"Eldridge GR, Hughey H, Rosenberger L, Martin SM, Shapiro AM, D\u2019Antonio E, Krejci KG, Shore N, Peterson J, Lukes AS (2021) Safety and immunogenicity of an adjuvanted Escherichia coli adhesin vaccine in healthy women with and without histories of recurrent urinary tract infections: results from a first-in-human phase 1 study. Hum Vaccin Immunother 17:1262\u20131270","journal-title":"Hum Vaccin Immunother"},{"key":"3553_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejmech.2017.03.022","volume":"131","author":"MI El-Gamal","year":"2017","unstructured":"El-Gamal MI, Brahim I, Hisham N, Aladdin R, Mohammed H, Bahaaeldin A (2017) Recent updates of carbapenem antibiotics. Eur J Med Chem 131:185\u2013195","journal-title":"Eur J Med Chem"},{"key":"3553_CR35","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3390\/biology10090889","volume":"10","author":"AA Elshamy","year":"2021","unstructured":"Elshamy AA, Saleh SE, Alshahrani MY, Aboshanab KM, Aboulwafa MM, Hassouna NA (2021) OXA-48 carbapenemase-encoding transferable plasmids of klebsiella pneumoniae recovered from Egyptian patients suffering from complicated urinary tract infections. Biology 10:889","journal-title":"Biology"},{"key":"3553_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-015-0054-7","volume":"4","author":"S Eshetie","year":"2015","unstructured":"Eshetie S, Unakal C, Gelaw A, Ayelign B, Endris M, Moges F (2015) Multidrug resistant and carbapenemase producing Enterobacteriaceae among patients with urinary tract infection at referral Hospital, Northwest Ethiopia. Antimicrob Resist Infect Control 4:1\u20138","journal-title":"Antimicrob Resist Infect Control"},{"key":"3553_CR37","doi-asserted-by":"crossref","unstructured":"Fibke, C. D., M. A. Croxen, H. M. Geum, M. Glass, E. Wong, B. P. Avery, D. Daignault, M. R. Mulvey, R. J. Reid-Smith, and E. J. Parmley. Year. Published. Genomic epidemiology of major extraintestinal pathogenic Escherichia coli lineages causing urinary tract infections in young women across Canada, p. ofz431. In, Open forum infectious diseases, 2019. Oxford University Press US.","DOI":"10.1093\/ofid\/ofz431"},{"key":"3553_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.07.029","author":"VS Forsyth","year":"2020","unstructured":"Forsyth VS, Himpsl SD, Smith SN, Sarkissian CA, Mike LA, Stocki JA, Sintsova A, Alteri CJ, Mobley HLT (2020) Optimization of an experimental vaccine to prevent Escherichia coli urinary tract infection. mBio. https:\/\/doi.org\/10.1016\/j.jgar.2019.07.029","journal-title":"mBio"},{"key":"3553_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jgar.2019.07.029","volume":"20","author":"VR Gajamer","year":"2020","unstructured":"Gajamer VR, Bhattacharjee A, Paul D, Ingti B, Sarkar A, Kapil J, Singh AK, Pradhan N, Tiwari HK (2020) High prevalence of carbapenemase, AmpC \u03b2-lactamase and aminoglycoside resistance genes in extended-spectrum \u03b2-lactamase-positive uropathogens from Northern India. J Glob Antimicrob Resist 20:197\u2013203","journal-title":"J Glob Antimicrob Resist"},{"key":"3553_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/14787210.2020.1813023","volume":"19","author":"JC Garc\u00eda-Betancur","year":"2021","unstructured":"Garc\u00eda-Betancur JC, Appel TM, Esparza G, Gales AC, Levy-Hara G, Cornistein W, Vega S, Nu\u00f1ez D, Cuellar L, Bavestrello L (2021) Update on the epidemiology of carbapenemases in Latin America and the Caribbean. Expert Rev Anti Infect Ther 19:197\u2013213","journal-title":"Expert Rev Anti Infect Ther"},{"key":"3553_CR41","doi-asserted-by":"publisher","first-page":"e0262984","DOI":"10.1371\/journal.pone.0262984","volume":"17","author":"SM Gatya Al-Mayahie","year":"2022","unstructured":"Gatya Al-Mayahie SM, D. R. d. T. Al-Guranie, A. A. Hussein, and Z. A. Bachai. (2022) Prevalence of common carbapenemase genes and multidrug resistance among uropathogenic Escherichia coli phylogroup B2 isolates from outpatients in Wasit Province\/Iraq. PLoS ONE 17:e0262984","journal-title":"PLoS ONE"},{"key":"3553_CR42","first-page":"223","volume":"12","author":"M Ghavidel","year":"2020","unstructured":"Ghavidel M, Gholamhosseini-Moghadam T, Nourian K, Ghazvini K (2020) Virulence factors analysis and antibiotic resistance of uropathogenic Escherichia coli isolated from patients in northeast of Iran. Iranian J Microbiol 12:223","journal-title":"Iranian J Microbiol"},{"key":"3553_CR43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3906\/sag-1805-100","volume":"49","author":"H Ghazvini","year":"2019","unstructured":"Ghazvini H, Taheri K, Edalati E, Miri A, Sedighi M, S. MIRKALANTARI. (2019) Virulence factors and antimicrobial resistance in uropathogenic Escherichiacoli strains isolated from cystitis and pyelonephritis. Turk J Med Sci 49:361\u2013367","journal-title":"Turk J Med Sci"},{"key":"3553_CR44","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1128\/AAC.02459-12","volume":"57","author":"WH Goessens","year":"2013","unstructured":"Goessens WH, van der Bij AK, van Boxtel R, Pitout JD, van Ulsen P, Melles DC, Tommassen J (2013) Antibiotic trapping by plasmid-encoded CMY-2 \u03b2-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli. Antimicrob Agents Chemother 57:3941\u20133949","journal-title":"Antimicrob Agents Chemother"},{"key":"3553_CR45","doi-asserted-by":"publisher","first-page":"ftz022","DOI":"10.1093\/femspd\/ftz022","volume":"77","author":"MJ Gonz\u00e1lez","year":"2019","unstructured":"Gonz\u00e1lez MJ, Da Cunda P, Notejane M, Zunino P, Scavone P, Robino L (2019) Fosfomycin tromethamine activity on biofilm and intracellular bacterial communities produced by uropathogenic Escherichia coli isolated from patients with urinary tract infection. Pathog Dis 77:ftz022","journal-title":"Pathog Dis"},{"key":"3553_CR46","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10123-022-00237-w","volume":"25","author":"E Gonz\u00e1lez-Villalobos","year":"2022","unstructured":"Gonz\u00e1lez-Villalobos E, Molina-L\u00f3pez J, Balc\u00e1zar JL (2022) Phage therapy for urinary tract infections: does it really work? Int Microbiol 25:665\u2013667","journal-title":"Int Microbiol"},{"key":"3553_CR47","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.2147\/IDR.S259967","volume":"13","author":"S Gurung","year":"2020","unstructured":"Gurung S, Kafle S, Dhungel B, Adhikari N, Shrestha UT, Adhikari B, Banjara MR, Rijal KR, Ghimire P (2020) Detection of OXA-48 gene in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from urine samples. Infect Drug Resist 13:2311","journal-title":"Infect Drug Resist"},{"key":"3553_CR48","doi-asserted-by":"publisher","first-page":"107638","DOI":"10.1016\/j.intimp.2021.107638","volume":"96","author":"M Habibi","year":"2021","unstructured":"Habibi M, Azimi S, Khoobbakht D, Roghanian P, Karam MRA (2021) Immunization with recombinant protein Ag43: UpaH with alum and 1, 25 (OH) 2D3 adjuvants significantly protects Balb\/C mice against urinary tract infection caused by uropathogenic Escherichia coli. Int Immunopharmacol 96:107638","journal-title":"Int Immunopharmacol"},{"key":"3553_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-019-4382-1","volume":"12","author":"DG Hagos","year":"2019","unstructured":"Hagos DG, Mezgebo TA, Berhane S, Medhanyie AA (2019) Biofilm and hemagglutinin formation: a Hallmark for drug resistant uropathogenic Escherichia coli. BMC Res Notes 12:1\u20135","journal-title":"BMC Res Notes"},{"key":"3553_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-020-00736-3","volume":"9","author":"D Hamza","year":"2020","unstructured":"Hamza D, Dorgham S, Ismael E, El-Moez SIA, Elhariri M, Elhelw R, Hamza E (2020) Emergence of \u03b2-lactamase-and carbapenemase-producing Enterobacteriaceae at integrated fish farms. Antimicrob Resist Infect Control 9:1\u201312","journal-title":"Antimicrob Resist Infect Control"},{"key":"3553_CR51","doi-asserted-by":"publisher","first-page":"e01892","DOI":"10.1128\/AAC.01892-18","volume":"63","author":"E Henly","year":"2019","unstructured":"Henly E, Dowling J, Maingay J, Lacey M, Smith T, Forbes S (2019) Biocide exposure induces changes in susceptibility, pathogenicity, and biofilm formation in uropathogenic Escherichia coli. Antimicrob Agents Chemother 63:e01892-e1818","journal-title":"Antimicrob Agents Chemother"},{"key":"3553_CR52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s13353-020-00542-y","volume":"61","author":"A Hozzari","year":"2020","unstructured":"Hozzari A, Behzadi P, Khiabani PK, Sholeh M, Sabokroo N (2020) Clinical cases, drug resistance, and virulence genes profiling in uropathogenic Escherichia coli. J Appl Genet 61:265\u2013273","journal-title":"J Appl Genet"},{"key":"3553_CR53","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MB-0014-2014","author":"DA Hufnagel","year":"2015","unstructured":"Hufnagel DA, Depas WH, Chapman MR (2015) The biology of the Escherichia coli extracellular matrix. Microbiol Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.MB-0014-2014","journal-title":"Microbiol Spectr"},{"key":"3553_CR54","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.1128\/AAC.01099-12","volume":"56","author":"A Hussain","year":"2012","unstructured":"Hussain A, Ewers C, Nandanwar N, Guenther S, Jadhav S, Wieler LH, Ahmed N (2012) Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-\u03b2-lactamase-producing lineage. Antimicrob Agents Chemother 56:6358\u20136365","journal-title":"Antimicrob Agents Chemother"},{"key":"3553_CR55","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/microorganisms8101593","volume":"8","author":"A Irrgang","year":"2020","unstructured":"Irrgang A, Tausch SH, Pauly N, Grobbel M, Kaesbohrer A, Hammerl JA (2020) First detection of GES-5-producing Escherichia coli from livestock\u2014an increasing diversity of carbapenemases recognized from german pig production. Microorganisms 8:1593","journal-title":"Microorganisms"},{"key":"3553_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1128\/CMR.00036-08","volume":"22","author":"GA Jacoby","year":"2009","unstructured":"Jacoby GA (2009) AmpC \u03b2-lactamases. Clin Microbiol Rev 22:161\u2013182","journal-title":"Clin Microbiol Rev"},{"key":"3553_CR57","first-page":"452","volume":"68","author":"N Jahandeh","year":"2015","unstructured":"Jahandeh N, Ranjbar R, Behzadi P, Behzadi E (2015) Uropathogenic Escherichia coli virulence genes: invaluable approaches for designing DNA microarray probes. Cent Eur J Urol 68:452\u2013458","journal-title":"Cent Eur J Urol"},{"key":"3553_CR58","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.chom.2012.01.001","volume":"11","author":"SS Justice","year":"2012","unstructured":"Justice SS, Hunstad DA (2012) UPEC hemolysin: more than just for making holes. Cell Host Microbe 11:4\u20135","journal-title":"Cell Host Microbe"},{"key":"3553_CR59","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4314\/ahs.v20i1.29","volume":"20","author":"AA Kadry","year":"2020","unstructured":"Kadry AA, Al-Kashef NM, El-Ganiny AM (2020) Distribution of genes encoding adhesins and biofilm formation capacity among Uropathogenic Escherichia coli isolates in relation to the antimicrobial resistance. Afr Health Sci 20:238\u2013247","journal-title":"Afr Health Sci"},{"key":"3553_CR60","doi-asserted-by":"publisher","first-page":"127010","DOI":"10.1016\/j.micres.2022.127010","volume":"259","author":"C Kenneally","year":"2022","unstructured":"Kenneally C, Murphy CP, Sleator RD, Culligan EP (2022) The urinary microbiome and biological therapeutics: novel therapies for urinary tract infections. Microbiol Res 259:127010","journal-title":"Microbiol Res"},{"key":"3553_CR61","first-page":"DC01","volume":"8","author":"A Khajuria","year":"2014","unstructured":"Khajuria A, Praharaj AK, Kumar M, Grover N (2014) Emergence of Escherichia coli, co-producing NDM-1 and OXA-48 carbapenemases, in urinary isolates, at a tertiary care centre at Central India. J Clin Diag Res 8:DC01","journal-title":"J Clin Diag Res"},{"key":"3553_CR62","first-page":"37","volume":"29","author":"E Khan","year":"2020","unstructured":"Khan E, Paul S, Kobayashi N, Khan T, Rahman M, Rahman M (2020) Antimicrobial resistance pattern and genetic characteristics of ESBL and carbapenemase-producing Escherichia coli at a tertiary care hospital in Bangladesh. Mymensingh Med J 29:37\u201342","journal-title":"Mymensingh Med J"},{"key":"3553_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-33568-8","volume":"8","author":"H-K Kong","year":"2018","unstructured":"Kong H-K, Pan Q, Lo W-U, Liu X, Law CO, Chan T-F, Ho P-L, Lau TC-K (2018) Fine-tuning carbapenem resistance by reducing porin permeability of bacteria activated in the selection process of conjugation. Sci Rep 8:1\u201311","journal-title":"Sci Rep"},{"key":"3553_CR64","doi-asserted-by":"publisher","first-page":"403","DOI":"10.33073\/pjm-2019-048","volume":"68","author":"B Kot","year":"2019","unstructured":"Kot B (2019) Antibiotic resistance among uropathogenic Escherichia coli. Pol J Microbiol 68:403","journal-title":"Pol J Microbiol"},{"key":"3553_CR65","doi-asserted-by":"publisher","first-page":"16669","DOI":"10.1073\/pnas.0607898104","volume":"104","author":"MC Lane","year":"2007","unstructured":"Lane MC, Alteri CJ, Smith SN, Mobley HL (2007) Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci 104:16669\u201316674","journal-title":"Proc Natl Acad Sci"},{"key":"3553_CR66","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1080\/08927014.2019.1657418","volume":"35","author":"J-H Lee","year":"2019","unstructured":"Lee J-H, Kim Y-G, Raorane CJ, Ryu SY, Shim J-J, Lee J (2019) The anti-biofilm and anti-virulence activities of trans-resveratrol and oxyresveratrol against uropathogenic Escherichia coli. Biofouling 35:758\u2013767","journal-title":"Biofouling"},{"key":"3553_CR67","unstructured":"Lewis, A. L., and N. M. Gilbert. 2020. Roles of the vagina and the vaginal microbiota in urinary tract infection: evidence from clinical correlations and experimental models. GMS Infect Dis 8."},{"key":"3553_CR68","doi-asserted-by":"publisher","first-page":"602691","DOI":"10.3389\/fmed.2021.602691","volume":"8","author":"X Li","year":"2021","unstructured":"Li X, Zhou K, Wang J, Guo J, Cao Y, Ren J, Guan T, Sheng W, Zhang M, Yao Z, Wang Q (2021) Diagnostic value of the fimbriae distribution pattern in localization of urinary tract infection. Front Med (lausanne) 8:602691","journal-title":"Front Med (lausanne)"},{"key":"3553_CR69","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3389\/fmicb.2016.01374","volume":"7","author":"A Liakopoulos","year":"2016","unstructured":"Liakopoulos A, Mevius D, Ceccarelli D (2016) A review of SHV extended-spectrum \u03b2-lactamases: neglected yet ubiquitous. Front Microbiol 7:1374","journal-title":"Front Microbiol"},{"key":"3553_CR70","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","volume":"215","author":"LK Logan","year":"2017","unstructured":"Logan LK, Weinstein RA (2017) The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis 215:S28\u2013S36","journal-title":"J Infect Dis"},{"key":"3553_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01509","author":"P Loubet","year":"2020","unstructured":"Loubet P, Ranfaing J, Dinh A, Dunyach-Remy C, Bernard L, Bruy\u00e8re F, Lavigne J-P, Sotto A (2020) Alternative therapeutic options to antibiotics for the treatment of urinary tract infections. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2020.01509","journal-title":"Front Microbiol"},{"key":"3553_CR72","doi-asserted-by":"publisher","first-page":"e00222","DOI":"10.1128\/mSphere.00222-18","volume":"3","author":"CL Luterbach","year":"2018","unstructured":"Luterbach CL, Forsyth VS, Engstrom MD, Mobley HL (2018) TosR-mediated regulation of adhesins and biofilm formation in uropathogenic Escherichia coli. Msphere 3:e00222-e218","journal-title":"Msphere"},{"key":"3553_CR73","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3390\/microorganisms9081726","volume":"9","author":"S Madzgalla","year":"2021","unstructured":"Madzgalla S, Duering H, Hey JC, Neubauer S, Feller K-H, Ehricht R, Pletz MW, Makarewicz O (2021) Assessment of phenotype relevant amino acid residues in TEM-\u03b2-lactamases by mathematical modelling and experimental approval. Microorganisms 9:1726","journal-title":"Microorganisms"},{"key":"3553_CR74","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/antibiotics9030108","volume":"9","author":"AT Mahmoud","year":"2020","unstructured":"Mahmoud AT, Salim MT, Ibrahem RA, Gabr A, Halby HM (2020) Multiple drug resistance patterns in various phylogenetic groups of hospital-acquired uropathogenic E. coli isolated from cancer patients. Antibiotics 9:108","journal-title":"Antibiotics"},{"key":"3553_CR75","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12223-019-00750-y","volume":"65","author":"S Malik","year":"2020","unstructured":"Malik S, Sidhu PK, Rana JS, Nehra K (2020) Managing urinary tract infections through phage therapy: a novel approach. Folia Microbiol (praha) 65:217\u2013231","journal-title":"Folia Microbiol (praha)"},{"key":"3553_CR76","doi-asserted-by":"publisher","first-page":"e401","DOI":"10.1016\/j.ijantimicag.2008.09.003","volume":"33","author":"HC Maltezou","year":"2009","unstructured":"Maltezou HC (2009) Metallo-\u03b2-lactamases in Gram-negative bacteria: introducing the era of pan-resistance? Int J Antimicrob Agents 33:e401-405","journal-title":"Int J Antimicrob Agents"},{"key":"3553_CR77","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fmicb.2020.00026","volume":"11","author":"AJ Mart\u00edn-Rodr\u00edguez","year":"2020","unstructured":"Mart\u00edn-Rodr\u00edguez AJ, Rhen M, Melican K, Richter-Dahlfors A (2020) Nitrate metabolism modulates biosynthesis of biofilm components in uropathogenic Escherichia coli and acts as a fitness factor during experimental urinary tract infection. Front Microbiol 11:26","journal-title":"Front Microbiol"},{"key":"3553_CR78","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fcimb.2020.00381","volume":"10","author":"C Massip","year":"2020","unstructured":"Massip C, Oswald E (2020) Siderophore-microcins in Escherichia coli: determinants of digestive colonization, the first step toward virulence. Front Cell Infect Microbiol 10:381","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"3553_CR79","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12941-021-00457-4","volume":"20","author":"FZ Matin","year":"2021","unstructured":"Matin FZ, Rezatofighi SE, Ardakani MR, Akhoond MR, Mahmoodi F (2021) Virulence characterization and clonal analysis of uropathogenic Escherichia coli metallo-beta-lactamase-producing isolates. Ann Clin Microbiol Antimicrob 20(1):50. https:\/\/doi.org\/10.1186\/s12941-021-00457-4","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"3553_CR80","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819000426","author":"M Matsukawa","year":"2019","unstructured":"Matsukawa M, Igarashi M, Watanabe H, Qin L, Ohnishi M, Terajima J, Iyoda S, Morita-Ishihara T, Tateda K, Ishii Y (2019) Epidemiology and genotypic characterisation of dissemination patterns of uropathogenic Escherichia coli in a community. Epidemiol Infect. https:\/\/doi.org\/10.1017\/S0950268819000426","journal-title":"Epidemiol Infect"},{"key":"3553_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000189674","volume":"3","author":"M Meredith","year":"2009","unstructured":"Meredith M, Chiavaroli C, Bauer HG (2009) Immunotherapy for recurrent urinary tract infections: effects of an Escherichia coli extract. Curr Urol 3:1\u20138","journal-title":"Curr Urol"},{"key":"3553_CR82","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/diagnostics11010007","volume":"11","author":"T Me\u0161trovi\u0107","year":"2021","unstructured":"Me\u0161trovi\u0107 T, Matija\u0161i\u0107 M, Peri\u0107 M, \u010cip\u010di\u0107 Paljetak H, Bare\u0161i\u0107 A, Verbanac D (2021) The role of gut, vaginal, and urinary microbiome in urinary tract infections: from bench to bedside. Diagnostics 11:7","journal-title":"Diagnostics"},{"key":"3553_CR83","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ijantimicag.2017.01.020","volume":"49","author":"ML Mezzatesta","year":"2017","unstructured":"Mezzatesta ML, La Rosa G, Maugeri G, Zingali T, Caio C, Novelli A, Stefani S (2017) In vitro activity of fosfomycin trometamol and other oral antibiotics against multidrug-resistant uropathogens. Int J Antimicrob Agents 49:763\u2013766","journal-title":"Int J Antimicrob Agents"},{"key":"3553_CR84","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.37506\/ijfmt.v15i2.14827","volume":"15","author":"AA Mhawesh","year":"2021","unstructured":"Mhawesh AA, Hamid DM, Ghasemian A (2021) Phylogrouping, serogrouping, virulence factors and carbapenemase genes among carbapenemase-producing Escherichia coli from urinary tract infections. Indian J Forensic Med Toxicol 15:2979\u20133003","journal-title":"Indian J Forensic Med Toxicol"},{"key":"3553_CR85","doi-asserted-by":"publisher","first-page":"13468","DOI":"10.1073\/pnas.1606324113","volume":"113","author":"LA Mike","year":"2016","unstructured":"Mike LA, Smith SN, Sumner CA, Eaton KA, Mobley HL (2016) Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection. Proc Natl Acad Sci 113:13468\u201313473","journal-title":"Proc Natl Acad Sci"},{"key":"3553_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13099-020-00382-5","volume":"12","author":"B Muktan","year":"2020","unstructured":"Muktan B, Thapa Shrestha U, Dhungel B, Mishra BC, Shrestha N, Adhikari N, Banjara MR, Adhikari B, Rijal KR, Ghimire P (2020) Plasmid mediated colistin resistant mcr-1 and co-existence of OXA-48 among Escherichia coli from clinical and poultry isolates: first report from Nepal. Gut Pathog 12:1\u20139","journal-title":"Gut Pathog"},{"key":"3553_CR87","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10534-009-9217-4","volume":"22","author":"SI M\u00fcller","year":"2009","unstructured":"M\u00fcller SI, Valdebenito M, Hantke K (2009) Salmochelin, the long-overlooked catecholate siderophore of Salmonella. Biometals 22:691\u2013695","journal-title":"Biometals"},{"key":"3553_CR88","doi-asserted-by":"publisher","first-page":"8829","DOI":"10.1073\/pnas.97.16.8829","volume":"97","author":"MA Mulvey","year":"2000","unstructured":"Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ (2000) Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U S A 97:8829\u20138835","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3553_CR89","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1089\/mdr.2018.0314","volume":"25","author":"LZ Nabti","year":"2019","unstructured":"Nabti LZ, Sahli F, Radji N, Mezaghcha W, Semara L, Aberkane S, Lounnas M, Solassol J, Didelot MN, Jean-Pierre H, Dumont Y, Godreuil S (2019) High prevalence of multidrug-resistant Escherichia coli in urine samples from inpatients and outpatients at a tertiary care hospital in S\u00e9tif, Algeria. Microb Drug Resist 25:386\u2013393","journal-title":"Microb Drug Resist"},{"key":"3553_CR90","doi-asserted-by":"publisher","first-page":"7263","DOI":"10.1007\/s00253-016-7532-6","volume":"100","author":"Y Nakamura","year":"2016","unstructured":"Nakamura Y, Yamamoto N, Kino Y, Yamamoto N, Kamei S, Mori H, Kurokawa K, Nakashima N (2016) Establishment of a multi-species biofilm model and metatranscriptomic analysis of biofilm and planktonic cell communities. Appl Microbiol Biotechnol 100:7263\u20137279","journal-title":"Appl Microbiol Biotechnol"},{"key":"3553_CR91","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.2147\/IDR.S256131","volume":"13","author":"Z Naziri","year":"2020","unstructured":"Naziri Z, Derakhshandeh A, Borchaloee AS, Poormaleknia M, Azimzadeh N (2020) Treatment failure in urinary tract infections: a warning witness for virulent multi-drug resistant ESBL-producing Escherichia coli. Infect Drug Resist 13:1839","journal-title":"Infect Drug Resist"},{"key":"3553_CR92","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/mdr.2019.0184","volume":"26","author":"F Neamati","year":"2020","unstructured":"Neamati F, Khorshidi A, Moniri R, Hosseini Tafreshi SA (2020) Molecular epidemiology of antimicrobial resistance of uropathogenic Escherichia coli isolates from patients with urinary tract infections in a tertiary teaching hospital in Iran. Microb Drug Resist 26:60\u201370","journal-title":"Microb Drug Resist"},{"key":"3553_CR93","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1089\/mdr.2018.0330","volume":"25","author":"A Noie Oskouie","year":"2019","unstructured":"Noie Oskouie A, Hasani A, Ahangarzadeh Rezaee M, M. H. Soroush Bar Haghi, A. Hasani, and E. Soltani. (2019) A relationship between O-serotype, antibiotic susceptibility and biofilm formation in Uropathogenic Escherichia coli. Microb Drug Resist 25:951\u2013958","journal-title":"Microb Drug Resist"},{"key":"3553_CR94","first-page":"107","volume":"3","author":"F Nojoomi","year":"2017","unstructured":"Nojoomi F, Ghasemian A (2017) Resistance and virulence factor determinants of carbapenem-resistant Escherichia coli clinical isolates in three hospitals in Tehran. Iran Infect Epidemiol Microbiol 3:107\u2013111","journal-title":"Iran Infect Epidemiol Microbiol"},{"key":"3553_CR95","doi-asserted-by":"publisher","first-page":"S521","DOI":"10.1093\/cid\/ciz824","volume":"69","author":"P Nordmann","year":"2019","unstructured":"Nordmann P, Poirel L (2019) Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria. Clin Infect Dis 69:S521\u2013S528","journal-title":"Clin Infect Dis"},{"key":"3553_CR96","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jiac.2016.12.013","volume":"23","author":"Y Ohno","year":"2017","unstructured":"Ohno Y, Nakamura A, Hashimoto E, Matsutani H, Abe N, Fukuda S, Hisashi K, Komatsu M, Nakamura F (2017) Molecular epidemiology of carbapenemase-producing Enterobacteriaceae in a primary care hospital in Japan, 2010\u20132013. J Infect Chemother 23:224\u2013229","journal-title":"J Infect Chemother"},{"key":"3553_CR97","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/82_2018_110","volume-title":"Escherichia coli, a Versatile Pathogen","author":"Y Paitan","year":"2018","unstructured":"Paitan Y (2018) Current trends in antimicrobial resistance of Escherichia coli. Escherichia coli, a Versatile Pathogen. Springer International Publishing, Cham, pp 181\u2013211"},{"key":"3553_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.46.1.1-11.2002","volume":"46","author":"A Philippon","year":"2002","unstructured":"Philippon A, Arlet G, Jacoby GA (2002) Plasmid-determined AmpC-type \u03b2-lactamases. Antimicrob Agents Chemother 46:1\u201311","journal-title":"Antimicrob Agents Chemother"},{"key":"3553_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13613-017-0334-x","volume":"7","author":"B Pilmis","year":"2017","unstructured":"Pilmis B, Jullien V, Tabah A, Zahar J-R, Brun-Buisson C (2017) Piperacillin\u2013tazobactam as alternative to carbapenems for ICU patients. Ann Intensive Care 7:1\u201317","journal-title":"Ann Intensive Care"},{"key":"3553_CR100","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/aam.aam_49_18","volume":"18","author":"U Pullanhi","year":"2019","unstructured":"Pullanhi U, Khan S, Vinod V, Mohan K, Kumar A (2019) Outcome of acute urinary tract infections caused by uropathogenic Escherichia coli with phenotypically demonstrable virulence factors. Ann Afr Med 18:138","journal-title":"Ann Afr Med"},{"key":"3553_CR101","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2021.2011578","author":"A Qasemi","year":"2021","unstructured":"Qasemi A, Rahimi F, Katouli M (2021) (2021) Clonal groups of extended-spectrum \u03b2-lactamase and biofilm producing uropathogenic Escherichia coli in Iran. Pathog Glob Health. https:\/\/doi.org\/10.1080\/20477724.2021.2011578","journal-title":"Pathog Glob Health"},{"key":"3553_CR102","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1128\/CMR.00001-07","volume":"20","author":"AM Queenan","year":"2007","unstructured":"Queenan AM, Bush K (2007) Carbapenemases: the versatile \u03b2-lactamases. Clin Microbiol Rev 20:440\u2013458","journal-title":"Clin Microbiol Rev"},{"key":"3553_CR103","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3389\/fchem.2019.00742","volume":"7","author":"K Qvortrup","year":"2019","unstructured":"Qvortrup K, Hultqvist LD, Nilsson M, Jakobsen TH, Jansen CU, Uhd J, Andersen JB, Nielsen TE, Givskov M, Tolker-Nielsen T (2019) Small molecule anti-biofilm agents developed on the basis of mechanistic understanding of biofilm formation. Front Chem 7:742","journal-title":"Front Chem"},{"issue":"7","key":"3553_CR104","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13756-018-0411-4","volume":"2018","author":"M Raeispour","year":"2018","unstructured":"Raeispour M, Ranjbar R (2018) Antibiotic resistance, virulence factors and genotyping of Uropathogenic Escherichia coli strains. Antimicrob Resist Infect Control 2018(7):118","journal-title":"Antimicrob Resist Infect Control"},{"key":"3553_CR105","first-page":"933","volume":"71","author":"K Ramakrishnan","year":"2005","unstructured":"Ramakrishnan K, Scheid DC (2005) Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician 71:933\u2013942","journal-title":"Am Fam Physician"},{"key":"3553_CR106","doi-asserted-by":"publisher","first-page":"126","DOI":"10.6026\/97320630017126","volume":"17","author":"V Ramakrishnan","year":"2021","unstructured":"Ramakrishnan V, Marialouis XA, Sankarasubramanian J, Santhanam A, Balakrishnan AS (2021) Whole Genomic analysis of a clinical isolate of Uropathogenic Escherichia coli strain of sequence type\u2014101 carrying the drug resistance NDM-7 in IncX3 plasmid. Bioinformation 17:126\u2013131","journal-title":"Bioinformation"},{"key":"3553_CR107","doi-asserted-by":"publisher","first-page":"e0202609","DOI":"10.1371\/journal.pone.0202609","volume":"13","author":"J Ranfaing","year":"2018","unstructured":"Ranfaing J, Dunyach-Remy C, Lavigne J-P, Sotto A (2018) Propolis potentiates the effect of cranberry (Vaccinium macrocarpon) in reducing the motility and the biofilm formation of uropathogenic Escherichia coli. PLoS ONE 13:e0202609","journal-title":"PLoS ONE"},{"key":"3553_CR108","doi-asserted-by":"publisher","first-page":"6795","DOI":"10.1128\/AAC.01345-16","volume":"60","author":"A Ranjan","year":"2016","unstructured":"Ranjan A, Shaik S, Mondal A, Nandanwar N, Hussain A, Semmler T, Kumar N, Tiwari SK, Jadhav S, Wieler LH (2016) Molecular epidemiology and genome dynamics of New Delhi metallo-\u03b2-lactamase-producing extraintestinal pathogenic Escherichia coli strains from India. Antimicrob Agents Chemother 60:6795\u20136805","journal-title":"Antimicrob Agents Chemother"},{"key":"3553_CR109","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1089\/mdr.2019.0485","volume":"27","author":"M Rasoulinasab","year":"2021","unstructured":"Rasoulinasab M, Shahcheraghi F, Feizabadi MM, Nikmanesh B, Hajihasani A, Sabeti S, Aslani MM (2021) Distribution of pathogenicity island markers and H-antigen types of Escherichia coli O25b\/ST131 isolates from patients with urinary tract infection in Iran. Microb Drug Resist 27:369\u2013382","journal-title":"Microb Drug Resist"},{"key":"3553_CR110","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0022-5347(17)37013-1","volume":"148","author":"JA Roberts","year":"1992","unstructured":"Roberts JA (1992) Vesicoureteral reflux and pyelonephritis in the monkey: a review. J Urol 148:1721\u20131725","journal-title":"J Urol"},{"key":"3553_CR111","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2217\/fmb-2017-0295","volume":"13","author":"AE Robinson","year":"2018","unstructured":"Robinson AE, Heffernan JR, Henderson JP (2018) The iron hand of uropathogenic Escherichia coli: the role of transition metal control in virulence. Future Microbiol 13:745\u2013756","journal-title":"Future Microbiol"},{"key":"3553_CR112","first-page":"17","volume":"5","author":"A Salehzadeh","year":"2017","unstructured":"Salehzadeh A, Ghauor M (2017) Phylogenetic classification of Escherichia coli isolated from urinary tract infections in the central regions of Guilan province. J Med Microbiol Infect Dis 5:17\u201320","journal-title":"J Med Microbiol Infect Dis"},{"key":"3553_CR113","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/QCO.0000000000000028","volume":"27","author":"C Schneeberger","year":"2014","unstructured":"Schneeberger C, Kazemier BM, Geerlings SE (2014) Asymptomatic bacteriuria and urinary tract infections in special patient groups: women with diabetes mellitus and pregnant women. Curr Opin Infect Dis 27:108\u2013114","journal-title":"Curr Opin Infect Dis"},{"key":"3553_CR114","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/toxins13080520","volume":"13","author":"E Schulz","year":"2021","unstructured":"Schulz E, Schumann M, Schneemann M, Dony V, Fromm A, Nagel O, Schulzke JD, B\u00fccker R (2021) Escherichia coli alpha-hemolysin HlyA induces host cell polarity changes, epithelial barrier dysfunction and cell detachment in human colon carcinoma caco-2 cell model via PTEN-dependent dysregulation of cell junctions. Toxins (Basel) 13:520","journal-title":"Toxins (Basel)"},{"key":"3553_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-019-1587-3","volume":"19","author":"C Shah","year":"2019","unstructured":"Shah C, Baral R, Bartaula B, Shrestha LB (2019) Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance. BMC Microbiol 19:1\u20136","journal-title":"BMC Microbiol"},{"key":"3553_CR116","first-page":"DC05","volume":"10","author":"D Shanmugam","year":"2016","unstructured":"Shanmugam D, Esak SB, Narayanaswamy A (2016) Molecular characterisation of nfsA gene in nitrofurantoin resistant uropathogens. J Clin Diag Res 10:DC05","journal-title":"J Clin Diag Res"},{"key":"3553_CR117","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.66481","author":"K Sharma","year":"2021","unstructured":"Sharma K, Dhar N, Thacker VV, Simonet TM, Signorino-Gelo F, Knott GW, McKinney JD (2021) Dynamic persistence of UPEC intracellular bacterial communities in a human bladder-chip model of urinary tract infection. Elife. https:\/\/doi.org\/10.7554\/eLife.66481","journal-title":"Elife"},{"key":"3553_CR118","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1128\/IAI.05621-11","volume":"79","author":"RR Spurbeck","year":"2011","unstructured":"Spurbeck RR, Stapleton AE, Johnson JR, Walk ST, Hooton TM, Mobley HL (2011) Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun 79:4753\u20134763","journal-title":"Infect Immun"},{"key":"3553_CR119","doi-asserted-by":"publisher","first-page":"e01195","DOI":"10.1128\/AAC.01195-18","volume":"62","author":"A Stewart","year":"2018","unstructured":"Stewart A, Harris P, Henderson A, Paterson D (2018) Treatment of infections by OXA-48-producing Enterobacteriaceae. Antimicrob Agents Chemother 62:e01195\u2013e01118","journal-title":"Antimicrob Agents Chemother"},{"key":"3553_CR120","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1021\/acs.jproteome.6b00061","volume":"15","author":"Q Su","year":"2016","unstructured":"Su Q, Guan T, He Y, Lv H (2016) Siderophore biosynthesis governs the virulence of uropathogenic Escherichia coli by coordinately modulating the differential metabolism. J Proteome Res 15:1323\u20131332","journal-title":"J Proteome Res"},{"key":"3553_CR121","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/antibiotics8030122","volume":"8","author":"B Suay-Garc\u00eda","year":"2019","unstructured":"Suay-Garc\u00eda B, P\u00e9rez-Gracia MT (2019) Present and future of carbapenem-resistant Enterobacteriaceae (CRE) infections. Antibiotics 8:122","journal-title":"Antibiotics"},{"key":"3553_CR122","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.UTI-0015-2012","author":"S Subashchandrabose","year":"2015","unstructured":"Subashchandrabose S, Mobley HLT (2015) Virulence and fitness determinants of uropathogenic Escherichia coli. Microbiol Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.UTI-0015-2012","journal-title":"Microbiol Spectr"},{"key":"3553_CR123","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.acuro.2015.04.008","volume":"40","author":"KA Taha Neto","year":"2016","unstructured":"Taha Neto KA, Nogueira Castilho L, Reis LO (2016) Oral vaccine (OM-89) in the recurrent urinary tract infection prophylaxis: a realistic systematic review with meta-analysis. Actas Urol Esp 40:203\u2013208","journal-title":"Actas Urol Esp"},{"key":"3553_CR124","doi-asserted-by":"publisher","first-page":"100897","DOI":"10.1016\/j.genrep.2020.100897","volume":"21","author":"M Talebi","year":"2020","unstructured":"Talebi M, Najar-Peerayeh S, Bakhshi B (2020) Hidden carbapenem resistance in the community-and hospital-associated OXA-48 gene-carrying uropathogenic Escherichia coli. Gene Rep 21:100897","journal-title":"Gene Rep"},{"key":"3553_CR125","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jsps.2018.02.023","volume":"26","author":"J Tenney","year":"2018","unstructured":"Tenney J, Hudson N, Alnifaidy H, Li JTC, Fung KH (2018) Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: a systematic literature review. Saudi Pharm J 26:678\u2013684","journal-title":"Saudi Pharm J"},{"key":"3553_CR126","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3389\/fmicb.2017.01566","volume":"8","author":"ME Terlizzi","year":"2017","unstructured":"Terlizzi ME, Gribaudo G, Maffei ME (2017) UroPathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol 8:1566","journal-title":"Front Microbiol"},{"key":"3553_CR127","doi-asserted-by":"publisher","first-page":"e10453","DOI":"10.7717\/peerj.10453","volume":"8","author":"N Tewawong","year":"2020","unstructured":"Tewawong N, Kowaboot S, Pimainog Y, Watanagul N, Thongmee T, Poovorawan Y (2020) Distribution of phylogenetic groups, adhesin genes, biofilm formation, and antimicrobial resistance of uropathogenic Escherichia coli isolated from hospitalized patients in Thailand. PeerJ 8:e10453","journal-title":"PeerJ"},{"key":"3553_CR128","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","volume":"431","author":"CL Tooke","year":"2019","unstructured":"Tooke CL, Hinchliffe P, Bragginton EC, Colenso CK, Hirvonen VH, Takebayashi Y, Spencer J (2019) \u03b2-lactamases and \u03b2-lactamase inhibitors in the 21st century. J Mol Biol 431:3472\u20133500","journal-title":"J Mol Biol"},{"key":"3553_CR129","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1128\/CMR.05035-11","volume":"25","author":"L Tzouvelekis","year":"2012","unstructured":"Tzouvelekis L, Markogiannakis A, Psichogiou M, Tassios P, Daikos G (2012) Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 25:682\u2013707","journal-title":"Clin Microbiol Rev"},{"key":"3553_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00492","author":"TB Valiatti","year":"2020","unstructured":"Valiatti TB, Santos FF, Santos AC, Nascimento JA, Silva RM, Carvalho E, Sinigaglia R, Gomes TA (2020) Genetic and virulence characteristics of a hybrid atypical enteropathogenic and uropathogenic Escherichia coli (aEPEC\/UPEC) Strain. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2020.00492","journal-title":"Front Cell Infect Microbiol"},{"key":"3553_CR131","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","volume":"8","author":"D van Duin","year":"2017","unstructured":"van Duin D, Doi Y (2017) The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence 8:460\u2013469","journal-title":"Virulence"},{"key":"3553_CR132","doi-asserted-by":"publisher","first-page":"e00066","DOI":"10.1128\/mBio.00066-11","volume":"2","author":"PD Vigil","year":"2011","unstructured":"Vigil PD, Stapleton AE, Johnson JR, Hooton TM, Hodges AP, He Y, Mobley HL (2011) Presence of putative repeat-in-toxin gene TosA in Escherichia coli predicts successful colonization of the urinary tract. mBio 2:e00066-00011","journal-title":"mBio"},{"key":"3553_CR133","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/35021219","volume":"406","author":"C Walsh","year":"2000","unstructured":"Walsh C (2000) Molecular mechanisms that confer antibacterial drug resistance. Nature 406:775\u2013781","journal-title":"Nature"},{"key":"3553_CR134","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/jac\/dki482","volume":"57","author":"J Walther-Rasmussen","year":"2006","unstructured":"Walther-Rasmussen J, H\u00f8iby N (2006) OXA-type carbapenemases. J Antimicrob Chemother 57:373\u2013383","journal-title":"J Antimicrob Chemother"},{"key":"3553_CR135","doi-asserted-by":"publisher","first-page":"e00877","DOI":"10.1128\/AAC.00877-17","volume":"61","author":"J Wang","year":"2017","unstructured":"Wang J, Yuan M, Chen H, Chen X, Jia Y, Zhu X, Bai L, Bai X, Fanning S, Lu J, Li J (2017) First report of Klebsiella oxytoca strain simultaneously producing NDM-1, IMP-4, and KPC-2 carbapenemases. Antimicrob Agents Chemother 61:e00877-17","journal-title":"Antimicrob Agents Chemother"},{"key":"3553_CR136","doi-asserted-by":"publisher","first-page":"13139","DOI":"10.1111\/jcmm.15920","volume":"24","author":"P Wang","year":"2020","unstructured":"Wang P, Wang J, Xie Z, Zhou J, Lu Q, Zhao Y, Dong C, Zou L (2020a) Depletion of multidrug-resistant uropathogenic Escherichia coli BC1 by ebselen and silver ion. J Cell Mol Med 24:13139\u201313150","journal-title":"J Cell Mol Med"},{"key":"3553_CR137","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jgar.2019.09.013","volume":"20","author":"Y Wang","year":"2020","unstructured":"Wang Y, Li H, Xie X, Wu X, Li X, Zhao Z, Luo S, Wan Z, Liu J, Fu L, Li X (2020b) In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli. J Glob Antimicrob Resist 20:351\u2013359","journal-title":"J Glob Antimicrob Resist"},{"key":"3553_CR138","doi-asserted-by":"publisher","first-page":"35","DOI":"10.21037\/atm.2016.12.71","volume":"5","author":"J Wu","year":"2017","unstructured":"Wu J, Miao Y, Abraham SN (2017) The multiple antibacterial activities of the bladder epithelium. Ann Transl Med 5:35","journal-title":"Ann Transl Med"},{"key":"3553_CR139","doi-asserted-by":"publisher","first-page":"103593","DOI":"10.1016\/j.micpath.2019.103593","volume":"134","author":"J Xicohtencatl-Cortes","year":"2019","unstructured":"Xicohtencatl-Cortes J, Cruz-Cordova A, Cazares-Dominguez V, Escalona-Venegas G, Zavala-Vega S, Arellano-Galindo J, Romo-Castillo M, Hernandez-Castro R, Ochoa SA, Luna-Pineda VM (2019) Uropathogenic Escherichia coli strains harboring TosA gene were associated to high virulence genes and a multidrug-resistant profile. Microb Pathog 134:103593","journal-title":"Microb Pathog"},{"key":"3553_CR140","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1089\/mdr.2015.0045","volume":"21","author":"M Yahiaoui","year":"2015","unstructured":"Yahiaoui M, Robin F, Bakour R, Hamidi M, Bonnet R, Messai Y (2015) Antibiotic resistance, virulence, and genetic background of community-acquired uropathogenic Escherichia coli from Algeria. Microb Drug Resist 21:516\u2013526","journal-title":"Microb Drug Resist"},{"key":"3553_CR141","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ijantimicag.2012.05.011","volume":"40","author":"JJ Yan","year":"2012","unstructured":"Yan JJ, Tsai LH, Wu JJ (2012) Emergence of the IMP-8 metallo-\u03b2-lactamase in the Escherichia coli ST131 clone in Taiwan. Int J Antimicrob Agents 40:281\u2013282","journal-title":"Int J Antimicrob Agents"},{"key":"3553_CR142","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/bju.14067","volume":"121","author":"B Yang","year":"2018","unstructured":"Yang B, Foley S (2018) First experience in the UK of treating women with recurrent urinary tract infections with the bacterial vaccine Uromune(\u00ae). BJU Int 121:289\u2013292","journal-title":"BJU Int"},{"key":"3553_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-021-02758-4","volume":"17","author":"J Yuan","year":"2021","unstructured":"Yuan J, Wang X, Shi D, Ge Q, Song X, Hu W, Wei D, Ge C, Li X, Hu C (2021) Extensive antimicrobial resistance and plasmid-carrying resistance genes in mcr-1-positive E. coli sampled in swine, in Guangxi, South China. BMC Vet Res 17:1\u201310","journal-title":"BMC Vet Res"},{"key":"3553_CR144","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/microorganisms9040799","volume":"9","author":"AS Zakaria","year":"2021","unstructured":"Zakaria AS, Edward EA, Mohamed NM (2021) Genomic insights into a colistin-resistant uropathogenic Escherichia coli strain of O23:H4-ST641 lineage harboring mcr-1.1 on a conjugative IncHI2 plasmid from Egypt. Microorganisms 9:799","journal-title":"Microorganisms"},{"key":"3553_CR145","first-page":"129","volume":"66","author":"BM Zalewska-Pi\u0105tek","year":"2019","unstructured":"Zalewska-Pi\u0105tek BM, Pi\u0105tek RJ (2019) Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains-review. Acta Biochim Pol 66:129\u2013138","journal-title":"Acta Biochim Pol"},{"key":"3553_CR146","doi-asserted-by":"publisher","first-page":"104196","DOI":"10.1016\/j.micpath.2020.104196","volume":"144","author":"F Zhao","year":"2020","unstructured":"Zhao F, Yang H, Bi D, Khaledi A, Qiao M (2020) A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections. Microb Pathog 144:104196","journal-title":"Microb Pathog"},{"key":"3553_CR147","doi-asserted-by":"crossref","unstructured":"Zykov, I. N., \u00d8. Samuelsen, L. Jakobsen, L. Sm\u00e5brekke, D. I. Andersson, A. Sundsfjord, and N. Frimodt-M\u00f8ller. 2018. Pharmacokinetics and pharmacodynamics of fosfomycin and its activity against extended-spectrum-\u03b2-lactamase-, plasmid-mediated AmpC-, and carbapenemase-producing Escherichia coli in a murine urinary tract infection model. Antimicrobial agents and chemotherapy 62: e02560-02517. Guideline available from: https:\/\/uroweb.org\/guidelines\/urological-infections\/chapter\/the-guideline","DOI":"10.1128\/AAC.02560-17"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-023-03553-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-023-03553-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-023-03553-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T00:27:31Z","timestamp":1729384051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-023-03553-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":147,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3553"],"URL":"https:\/\/doi.org\/10.1007\/s00203-023-03553-5","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,8]]},"assertion":[{"value":"28 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The project was approved by the Ethical Committee of Tabriz University of Medical Sciences, Tabriz with code number IR.TBZMED.REC.1400.577.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors agreed and gave consent to publish the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"226"}}